https://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progressionContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progressionhttps://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progression#u18062Tue, 30 Jun 2026 01:06:42 +0000Research indicates the joint supplement glucosamine may accelerate the shift from mild cognitive impairment to Alzheimer's disease. Users face a 25% higher risk of this progression. Evidence also connects the supplement to an increased risk of death.What's confirmed:Glucosamine is linked to a 25% higher risk of progressing from mild cognitive impairment to Alzheimer's disease.The supplement is associated with an increased risk of mortality.Glucosamine is a common over-the-counter supplement used for joint pain.Still unconfirmed:Glucosamine might increase the general risk for Alzheime https://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progressionhttps://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progression#u13001Thu, 25 Jun 2026 15:07:04 +0000Research from the University of Florida's McKnight Brain Institute indicates that glucosamine can accelerate the transition from mild cognitive impairment to Alzheimer's disease. Users of the supplement face a 25% higher likelihood of progressing to dementia. New data also connects the supplement to an increased risk of death.What's confirmed:Glucosamine use is associated with a 25% increase in progression from mild cognitive impairment to dementia.The University of Florida's McKnight Brain Institute conducted the analysis.Findings were published in Nature Metabolism on June 9, https://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progressionhttps://www.live-feeds.com/feed/joint-pain-supplement-tied-to-faster-alzheimer-s-progression#u8738Mon, 22 Jun 2026 20:01:29 +0000A study from the University of Florida's McKnight Brain Institute suggests glucosamine may accelerate the transition from mild cognitive impairment to Alzheimer's disease. Researchers found a 25% higher likelihood of developing dementia among users of the joint pain supplement. The findings were published in Nature Metabolism on June 9, 2026.What's confirmed:Glucosamine is a popular over-the-counter supplement used for joint pain and arthritis.A study published in Nature Metabolism on June 9, 2026, links glucosamine use to a 25% higher likelihood of progressing from mild cognitive im